Waters Corporation Elects Flemming Ornskov to Board of Directors

June 22, 2017 04:30 AM Pacific Daylight Time MILFORD, Mass.–(BUSINESS WIRE)–Waters Corporation (NYSE: WAT) today announced Dr. Flemming Ornskov, Chief Executive Officer of Shire plc, has been elected as a Director of Waters® Corporation effective today. “It is an honor to welcome Flemming Ornskov to our Board of Directors,” said Christopher J. O’Connell, Waters Corporation President... Read more

DiaSorin and QIAGEN sign collaboration to expand liaison test menu through adoption of select QIAGEN assays

June 22, 2017 – Saluggia, Italy; Hilden, Germany, and Germantown, Maryland – DiaSorin (FTSE Italy Mid Cap: DIA) and QIAGEN (NASDAQ: QGEN; Frankfurt Stock Exchange: QIA) announced today a new collaboration to develop new tests for DiaSorin’s LIAISON family of analyzers based on a review and selection process involving QIAGEN’s assay technologies. The adoption of... Read more

French Health-system approves reimbursement of QIAGEN’s QuantiFERON latent TB test

Gold-standard test for latent tuberculosis infection will be covered by national health insurance Hilden, Germany, and Paris, France, June 22, 2017 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that France’s Ministry of Health and Social Affairs has approved reimbursement by the national health insurance system for QIAGEN’s QuantiFERON-TB® Gold Plus (QFT-Plus®)... Read more

CW Analytical Expands Offerings With Orange Photonics Partnership

OAKLAND, Calif., June 22, 2017 /PRNewswire/ — CW Analytical Laboratories Inc., a leading laboratory in California’sCannabis industry, and Orange Photonics Inc, producer of portable Cannabinoid analyzers, are pleased to announce their distribution partnership throughout the state of California. Utilizing a modified version of the same high pressure liquid chromatography currently used to measure cannabinoid content in a laboratory setting, LightLab™... Read more

Canopy Biosciences Announces Distribution Agreement with Cosmo Bio for Japan Life Science Market

Canopy Biosciences signs agreement with Cosmo Bio to sell gene engineering products in Japan ST. LOUIS, June 22, 2017 /PRNewswire/ — Canopy BiosciencesTM, LLC (“Canopy Biosciences”), an emerging provider of gene editing and personalized medicine technologies, announced a distributor agreement with Cosmo Bio Co., Ltd. (“Cosmo Bio“) for its TUNR Flexible Gene Editing technology in Japan. ... Read more

Online monitoring of chlorine (free or total) in wastewater streams

6/21/2017 Metrohm Process Analytics is pleased to present a dedicated solution for the online monitoring of free chlorine or total chlorine in wastewater streams. This turn-key solution uses photometric determination and is performed on the ICON Analyzer, a dedicated online photometer for water and wastewater analysis. Chlorine is one of the most commonly produced chemical... Read more

Beijing 4P Health Research Institute initiates China’s “100K Wellness Pioneer Project” using UniteGen and Sapientia™ integrated platform

Commercial agreement with Congenica supports UniteGen’s goal of achieving the world’s largest human genome database Cambridge, UK – 21st June –  Congenica’s Sapientia™ clinical genome analysis software platform will be used by China-based UniteGen to carry out whole genome sequencing (WGS) processing and analysis as part of China’s “100K Wellness Pioneer Project”, hosted by Beijing... Read more

Seegene Signed MOU with a Mexico Government Agriculture Agency for Collaborative Development of Non-human MDx Assay

MOU signed between Mexico SAGARPA’s INIFAP and Seegene for collaborative product development and clinical study: (from middle to left) INIFAP’s bovine TB Director Dr. Ferando Otero, Head of Seegene Institute of Life Sciences Dr. Nackmoon … SEOUL, South Korea, June 21, 2017 /PRNewswire/ — Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies headquartered... Read more

BASi Names Dr. Gregory C. Davis to Board of Directors

PRESS RELEASE UPDATED: JUN 20, 2017 WEST LAFAYETTE, IN, June 20, 2017 (Newswire.com) – Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced that the board of directors unanimously elected Dr. Gregory C. Davis as a director effective June 14, 2017. This action brings the number of directors to four. Larry Boulet, BASi’s Chairman... Read more